Clinical Trials Browser

Phase 1/2 × Lymphoma × Lamivudine × Clear all

NCT01528865 2016-03-11

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Virus Diseases